DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Neurocognitive Disorders: Systematic Review of Approved (2008–2024) and Pipeline Phase III Medications

Innov Clin Neurosci. 2025;22(10–12):57–71. by Jayant Totlani, DO; Muhammad Arsalan Bashir, MBBS; Laurel Tay, BA; Ashley Ngor, BS; Alexander J. Steiner, PsyD; Drew Hirsch, BS; Lorena Contreras, MA; Sabrina Renteria,

Bias in Assessing Decision-making Capacity in Patients with Serious Mental Illness in Hospital Settings

Innov Clin Neurosci. 2025;22(10–12):52–56. by Alexandria Nasr, MD; Larrilyn Grant, MD; Jennifer Golida, BS; and Bailey Hangen, BS, MS All authors are affiliated with the Boonshoft School of Medicine at

Adaptation, Translation, and Validation of the Perceived Parenting Style Scale in Pakistan Using ITC Protocol

Innov Clin Neurosci. 2025;22(10–12):72–77. by Anam Shahid, PhD; Alia Asmat, PhD; and Sunny Singh, MD Dr. Shahid and Dr. Singh are with the Nova Scotia Health Authority in Sydney, Nova

Selected Abstracts from CNS Summit 2025

Innov Clin Neur. 2025;22(10–12):78–85. November 2–5, 2025 in Boston, Massachusetts. Artificial intelligence (AI)/machine-based learning Digital phenotyping with real-world data to identify candidates for anti-CGRP migraine treatment Presenters: Giorgio Pietro Biondetti;

Risk Management: I’ve Been Sued, Now What! Part 4: Closing Statements, Jury Deliberations, Verdicts, Judgments, and Appeals

Innov Clin Neurosci. 2025;22(10–12):86–87. by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation

“You’re Not Crazy”: A Case of New-onset AI-associated Psychosis

Watch Journal Review Innov Clin Neurosci. 2025;22(10–12):11–13. by Joseph M. Pierre, MD; Ben Gaeta, MD; Govind Raghavan, MD; and Karthik V. Sarma, MD, PhD All authors are with the University